4
Changes in Ownership
Organogenesis Holdings Inc. Filed Acc 0001062993-25-003224
Chief Financial Officer acquired 165,156 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Francisco David Chief Financial Officer | 2025-02-19 | Grant or award | +165,156 | 559,095 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Francisco David Chief Financial Officer | 2025-02-19 | Grant or award · Stock Option (Right to Buy) | +170,841 | 170,841 | D: show line 2 in the form |
Loading xslF345X05/form4.xml…